Bvf Inc/il

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 51Value: $2.5BLatest: 2025Q1

BVF INC/IL is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 51 holdings worth $2.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "FBRX",
  "NAMS",
  "RVMD",
  "GLPG",
  "TCRX",
  "ANNX",
  "OLMA",
  "GPCR",
  "MIRM",
  "THRD",
  "TYRA",
  "KYMR",
  "GLUE",
  "ALLK",
  "AVTX",
  "EPIX",
  "OVID",
  "PVLA",
  "RPTX",
  "SABS",
  "SEPN",
  "IONS",
  null,
  "GHRS",
  "MOLN",
  "ZYME",
  "IVA",
  null,
  "RAPT",
  "PTGX",
  "FDMT",
  "TENX",
  "MLTX",
  "ACIU",
  "GLYC",
  "CDTX",
  "ELDN",
  "IMUX",
  "IKNA",
  "ITOS",
  "KURA",
  "VERV",
  "VSTM",
  "VIGL",
  "XOMA",
  "FHTX",
  "XNCR",
  "CELC",
  "CGEM",
  "CTMX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 51
Total Value: 2453567172
Accession Number: 0000921895-25-001528
Form Type: 13F-HR
CIK: bvf-incil
Manager Name: Bvf-Incil

Data Enrichment

96% identified

49 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

51 positions • $2.5B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 3

Sort by:

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:19.8M

Value:$771.7M

% of Portfolio:31.5% ($771.7M/$2.5B)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:1.7M

Value:$197.1M

% of Portfolio:8.0% ($197.1M/$2.5B)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:5.0M

Value:$176.2M

% of Portfolio:7.2% ($176.2M/$2.5B)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:5.2M

Value:$141.3M

% of Portfolio:5.8% ($141.3M/$2.5B)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

Shares:2.8M

Value:$126.0M

% of Portfolio:5.1% ($126.0M/$2.5B)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:2.6M

Value:$124.5M

% of Portfolio:5.1% ($124.5M/$2.5B)

GH Research PLC

GHRS|G3855L106

Shares:8.8M

Value:$97.4M

% of Portfolio:4.0% ($97.4M/$2.5B)

XOMA Royalty Corp

XOMA|98419J206

Shares:3.0M

Value:$59.5M

% of Portfolio:2.4% ($59.5M/$2.5B)

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:1.9M

Value:$57.7M

% of Portfolio:2.4% ($57.7M/$2.5B)

Zymeworks Inc.

ZYME|98985Y108

Shares:4.3M

Value:$51.3M

% of Portfolio:2.1% ($51.3M/$2.5B)

Kura Oncology, Inc.

KURA|50127T109

Shares:7.8M

Value:$51.2M

% of Portfolio:2.1% ($51.2M/$2.5B)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:5.8M

Value:$43.5M

% of Portfolio:1.8% ($43.5M/$2.5B)

AC Immune SA

ACIU|H00263105

Shares:19.8M

Value:$37.1M

% of Portfolio:1.5% ($37.1M/$2.5B)

Tyra Biosciences, Inc.

TYRA|90240B106

Shares:3.9M

Value:$36.7M

% of Portfolio:1.5% ($36.7M/$2.5B)

GALAPAGOS NV

GLPG|36315X101

Shares:1.5M

Value:$36.5M

% of Portfolio:1.5% ($36.5M/$2.5B)

Celcuity Inc.

CELC|15102K100

Shares:3.5M

Value:$35.0M

% of Portfolio:1.4% ($35.0M/$2.5B)

Verve Therapeutics, Inc.

VERV|92539P101

Shares:6.9M

Value:$31.6M

% of Portfolio:1.3% ($31.6M/$2.5B)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:1.8M

Value:$30.7M

% of Portfolio:1.2% ($30.7M/$2.5B)

Xencor Inc

XNCR|98401F105

Shares:2.7M

Value:$29.2M

% of Portfolio:1.2% ($29.2M/$2.5B)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

Shares:5.7M

Value:$26.3M

% of Portfolio:1.1% ($26.3M/$2.5B)

Instrument	Shares		Other Manager	Value	% of Portfolio
MoonLake Immunotherapeutics(MLTXcusip61559X104)	19.8M	QoQ 0.00% (-0) YoY -9.19% (-2.0M)	All Managers (Combined)	$771.7M	31.5% ($771.7M/$2.5B)	QoQ -27.84% (-$297.8M) YoY -29.36% (-$320.9M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	1.7M	QoQ +21.76% (+302.2K) YoY NEW(+1.7M)	All Managers (Combined)	$197.1M	8.0% ($197.1M/$2.5B)	QoQ +67.85% (+$79.7M) YoY NEW(+$197.1M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	5.0M	QoQ +19.16% (-801.2K) YoY -16.69% (-998.8K)	All Managers (Combined)	$176.2M	7.2% ($176.2M/$2.5B)	QoQ -3.66% (-$6.7M) YoY -8.60% (-$16.6M)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	5.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$141.3M	5.8% ($141.3M/$2.5B)	QoQ -31.96% (-$66.4M) YoY -31.91% (-$66.2M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	2.8M	QoQ 0.00% (+0) YoY -36.00% (-1.6M)	All Managers (Combined)	$126.0M	5.1% ($126.0M/$2.5B)	QoQ +8.94% (+$10.3M) YoY +14.76% (-$16.2M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	2.6M	QoQ +35.52% (+675.0K) YoY -31.44% (-1.2M)	All Managers (Combined)	$124.5M	5.1% ($124.5M/$2.5B)	QoQ +69.79% (+$51.2M) YoY +14.60% (-$15.9M)
GH Research PLC(GHRScusipG3855L106)	8.8M	QoQ -15.11% (-1.6M) YoY -15.11% (-1.6M)	All Managers (Combined)	$97.4M	4.0% ($97.4M/$2.5B)	QoQ +33.74% (-$24.6M) YoY -12.17% (-$13.5M)
XOMA Royalty Corp(XOMAcusip98419J206)	3.0M	QoQ -17.90% (-650.7K) YoY -17.90% (-650.7K)	All Managers (Combined)	$59.5M	2.4% ($59.5M/$2.5B)	QoQ -37.74% (-$36.0M) YoY -31.97% (-$27.9M)
IONIS PHARMACEUTICALS INC(IONScusip462222100)	1.9M	QoQ NEW(+1.9M) YoY -21.21% (-515.2K)	All Managers (Combined)	$57.7M	2.4% ($57.7M/$2.5B)	QoQ NEW(+$57.7M) YoY -45.16% (-$47.6M)
Zymeworks Inc.(ZYMEcusip98985Y108)	4.3M	QoQ 0.00% (-0) YoY -26.59% (-1.6M)	All Managers (Combined)	$51.3M	2.1% ($51.3M/$2.5B)	QoQ -18.64% (-$11.8M) YoY -16.89% (-$10.4M)
Kura Oncology, Inc.(KURAcusip50127T109)	7.8M	QoQ +202.01% (+5.2M) YoY +62.00% (-3.0M)	All Managers (Combined)	$51.2M	2.1% ($51.2M/$2.5B)	QoQ +128.85% (+$28.8M) YoY -49.87% (-$50.9M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	5.8M	QoQ 0.00% (-0) YoY +79.89% (-2.6M)	All Managers (Combined)	$43.5M	1.8% ($43.5M/$2.5B)	QoQ -37.84% (-$26.5M) YoY -20.08% (-$10.9M)
AC Immune SA(ACIUcusipH00263105)	19.8M	QoQ +1.53% (-300.0K) YoY +36.03% (-5.3M)	All Managers (Combined)	$37.1M	1.5% ($37.1M/$2.5B)	QoQ -29.67% (-$15.6M) YoY -14.05% (-$6.1M)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	3.9M	QoQ 0.00% (-0) YoY -15.38% (-717.0K)	All Managers (Combined)	$36.7M	1.5% ($36.7M/$2.5B)	QoQ -33.09% (-$18.1M) YoY -52.01% (-$39.8M)
GALAPAGOS NV(GLPGcusip36315X101)	1.5M	QoQ -7.32% (-115.0K) YoY -21.96% (-409.4K)	All Managers (Combined)	$36.5M	1.5% ($36.5M/$2.5B)	QoQ -15.34% (-$6.6M) YoY -39.12% (-$23.5M)
Celcuity Inc.(CELCcusip15102K100)	3.5M	QoQ 0.00% (-0) YoY NEW(+3.5M)	All Managers (Combined)	$35.0M	1.4% ($35.0M/$2.5B)	QoQ -22.76% (-$10.3M) YoY NEW(+$35.0M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	6.9M	QoQ 0.00% (-0) YoY +962.16% (+6.3M)	All Managers (Combined)	$31.6M	1.3% ($31.6M/$2.5B)	QoQ -18.97% (-$7.4M) YoY +265.51% (+$22.9M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	1.8M	QoQ 0.00% (-0) YoY +117.88% (-958.4K)	All Managers (Combined)	$30.7M	1.2% ($30.7M/$2.5B)	QoQ -36.17% (-$17.4M) YoY -12.00% (-$4.2M)
Xencor Inc(XNCRcusip98401F105)	2.7M	QoQ +19.72% (-451.4K) YoY NEW(+2.7M)	All Managers (Combined)	$29.2M	1.2% ($29.2M/$2.5B)	QoQ -44.56% (-$23.4M) YoY NEW(+$29.2M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	5.7M	QoQ +104.74% (+2.9M) YoY NEW(+5.7M)	All Managers (Combined)	$26.3M	1.1% ($26.3M/$2.5B)	QoQ +36.89% (+$7.1M) YoY NEW(+$26.3M)